CoChat

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk.

Carr, Molly C., Brunzell, John D. · 2004 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.

Abstract

Regional body fat distribution has an important influence on metabolic and cardiovascular risk factors. Increased abdominal (visceral) fat accumulation is a risk factor for coronary artery disease (CAD), dyslipidemia, hypertension, stroke, and type 2 diabetes. The recent emphasis on treatment of the dyslipidemia of the metabolic syndrome (hypertriglyceridemia, reduced high-density lipoprotein, and increased small, dense low-density lipoprotein particle number) has compelled practitioners to consider lipid-lowering therapy in a greater number of their patients, as one in two individuals over age 50 has the metabolic syndrome. Individuals with the metabolic syndrome typically have normal low-density lipoprotein cholesterol levels, and current lipid-lowering guidelines may underestimate their cardiovascular risk. Two subgroups of patients with the metabolic syndrome are at particularly high risk for premature CAD. One, individuals with type 2 diabetes, accounts for 20–30% of early cardiovascular disease. The second, familial combined hyperlipidemia, accounts for an additional 10–20% of premature CAD. Familial combined hyperlipidemia is characterized by the metabolic syndrome in addition to a disproportionate elevation of apolipoprotein B levels. The measurement of fasting glucose and apolipoprotein B, in addition to the fasting lipid profile, can help to estimate CAD risk in patients with the metabolic syndrome.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2004-0432

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 493

Metadata

Authors
Carr, M. C., & Brunzell, J. D.
Affiliations
University of Washington (US)
Corresponding author
Carr, Molly C.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2004-06-01
Volume
89
Issue
6
Pages
2601-2607
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2163802092
Cited by
493
References
83
Citations by year
2026: 4 · 2025: 10 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 19 · 2020: 20 · 2019: 17 · 2018: 46 · 2017: 19 · 2016: 18 · 2015: 18 · 2014: 29 · 2013: 27 · 2012: 20
FWCI
4.41
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (P01HL030086, HL3-0086, HL 64322, R01HL064322)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 02456)
  • National Center for Research Resources (K23RR16067, M01-RR 00037, K23RR016067, M01RR000037)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Keywords
abdominal obesity, visceral fat, metabolic syndrome, dyslipidemia, type 2 diabetes, familial combined hyperlipidemia, coronary artery disease risk, apolipoprotein B, lipid-lowering therapy, cardiovascular risk assessment, fasting blood glucose, small dense LDL, HDL cholesterol
MeSH terms
Abdomen, Coronary Artery Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, Humans, Hyperlipidemia, Familial Combined, Obesity, Risk Factors, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.